Filing Details

Accession Number:
0001493152-20-016100
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-17 16:30:32
Reporting Period:
2020-08-13
Accepted Time:
2020-08-17 16:30:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
868278 Prophase Labs Inc. PRPH Pharmaceutical Preparations (2834) 232577138
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457896 William Ted Karkus 621 N. Shady Retreat Road
Doylestown PA 18901
Ceo & Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.005 Disposition 2020-08-13 50,000 $2.75 2,419,528 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, Par Value $0.005 40,000 Indirect By Son
Common Stock, Par Value $0.005 40,000 Indirect By Son
Footnotes
  1. These shares were sold in a private transaction to Louis Gleckel, a director of the Issuer, pursuant to the terms of a Stock Purchase Agreement.